The Stroke Trials Network (NIH StrokeNet) is designed to maximize efficiencies to prioritize, harmonize and streamline the development of high-quality, multi-site clinical trials focused on key interventions in stroke prevention, treatment, and recovery. Early phase 1-2 exploratory and confirmatory phase 3 clinical trials as well as biomarker-validation studies that are immediately preparatory to trials will be coordinated through Regional Coordinating Stroke Centers, the National Clinical Coordinating Center, and the National Data Management Center. The network provides centralized infrastructure and support for data management and integration as well as opportunities for data sharing. Finally, strong multidisciplinary collaboration within and among sites will ensure successful trial completion. A steady pipeline of new trials developed outside as well as within StrokeNet, along with international and private-public partnerships facilitated through this program, will all serve to enhance the public health impact of the NINDS’s investment in stroke clinical trials.
Network website: http://www.nihstrokenet.org/
How to Apply to StrokeNet
Working with StrokeNet is a cooperative venture between NINDS, the StrokeNet network, and the applicant. The NINDS will provide guidance to potential applicants with input from the Office of Clinical Research (OCR), other applicable NINDS extramural program staff, and the StrokeNet Executive Committee. Potential applicants should contact NINDS OCR in order to discuss the feasibility of conducting the proposed trial through the StrokeNet infrastructure.
There are three mechanisms available for potential applicants:
Referral/review Process for StrokeNet Applications
Please refer to the StrokeNet website for the full process for solicitation and review of projects for NIH StrokeNet.
Current StrokeNet-supported Studies
Scott Janis, PhD
NINDS Office of Clinical Research
Last updated July 15, 2014